PHVS Latest Headlines

3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts

at www.tipranks.com (Mon, 15-Dec 10:50 PM)

Pharvaris (PHVS) Receives a Buy from Morgan Stanley

at www.tipranks.com (Mon, 15-Dec 9:05 AM)

PHVS Study Shows Deucrictibant Cuts HAE Attack Relief Time to Just 1.28 Hours: Phase 3 Results Impress

Market Chameleon (Wed, 3-Dec 10:29 AM)

Pharvaris Reports Rapid Symptom Relief and Broad Efficacy for Deucrictibant in Landmark Phase 3 HAE Study

Market Chameleon (Wed, 3-Dec 7:29 AM)